-
translational cancer research. Omics based strategies, such as (epi-)genomics and transcriptomics, are opening unprecedented potential for developing novel precision oncology tools for improved diagnosis
-
critical roles of ion channels—particularly the TRP superfamily—in physiological and pathological processes. Our interdisciplinary approach spans from foundational electrophysiology to translational models
-
systems and computational biology. Models include yeast, fly, mouse, and pluripotent human cell systems. Research groups have access to state-of-the-art research and top-notch support core facilities and
-
sequencing and transcriptomics, and iPSC-based disease modeling to better understand the genetic etiologies of intractable epilepsy. The team is part of the European STXBP1 consortium . About the project
-
on cancer metastasis and novel metabolic pathways. We exploit mouse models, genetic engineering, metabolomics and single cell & spatial multi-omics analysis to gain groundbreaking insights into metabolism as
-
drive neuroinflammation in synucleinopathies and other neurodegenerative diseases. The candidate will employ advanced in vivo models and spatial technologies to dissect the roles of tissue-resident
-
students who are eager to develop and apply artificial intelligence techniques and mechanistic mathematical models to explore fundamental questions in biology. The PhD program is organized in partnership
-
validate the identified key (epi)genetic molecular and explore their therapeutic potential in vitro and in vivo disease models. Profile The candidate should: have an MSc in Systems Biology, Molecular Biology
-
commitment are essential. Access to state-of-the art tools and infrastructure within an excellence-based research institute. A stimulating and supportive international research environment. Various training